China missed a key climate target in 2024 and emissions in the world's second-largest economy rose slightly as coal remained dominant despite record renewable additions, official data showed Friday.

LEK, a consultancy, estimates that during that time, the total value of drugs licensed worldwide from China rose 15-fold, to $48bn (see chart 2). In November Merck paid $588m to LaNova Medicines ...